Mixing Alcohol and Synthetic Cannabinoids Hit Mouse Hearts Harder Than Either Drug Alone

Both alcohol and the synthetic cannabinoid CP55,940 independently caused dose-dependent declines in heart contractile function in mice. When combined, the cardiac depression was worse than either drug alone. Intravenous administration of the CB1 receptor antagonist rimonabant largely restored normal heart function, while brain-only administration only partially helped, implicating both central and peripheral CB1 receptor signaling.

Mouse study using pressure-volume hemodynamic measurements to assess left ventricular performance after acute alcohol ingestion, intravenous synthetic cannabinoid (CP55,940) administration, or both combined. CB1 receptor antagonist rimonabant was given either intravenously or intracerebroventricularly.

Polydrug use combining alcohol and synthetic cannabinoids is increasing, particularly among young adults, and has been linked to fatal outcomes. This study provides mechanistic evidence for why the combination is especially dangerous for the heart and identifies a potential therapeutic approach.

As synthetic cannabinoids become more prevalent and polydrug use increases, understanding drug interaction effects on the heart is critical. The finding that CB1 receptor antagonism can reverse combined alcohol-synthetic cannabinoid cardiac damage could inform emergency treatment protocols.

Animal study using mice, which may not directly translate to human physiology. Used a single synthetic cannabinoid (CP55,940), and results may differ with other synthetic cannabinoids found in consumer products. Acute exposure model does not address chronic use effects.